News

Cosmo Pharmaceuticals on Friday reported the renewal of its multi-year manufacturing and supply agreement with Takeda ...
Palisade Bio, Inc. (($PALI)) announced an update on their ongoing clinical study. Study Overview: Palisade Bio, Inc. has completed a Phase 1 ...
While complementary therapies won’t treat the underlying cause of ulcerative colitis (UC), they can help you manage your symptoms and improve your overall quality of life.
"Managing ulcerative colitis often requires a personalized approach and ongoing adjustments based on the patient's response to therapy, especially for patients with more severe cases," noted lead ...
The number of patients using so-called advanced therapies—medicines designed to target a specific part of the immune system—to tackle ulcerative colitis rose rapidly between 2004 and 2023 ...
Ulcerative colitis is the most common cause of proctitis, but it's not the only cause. You can get proctitis from a STD or other infection, medicine, radiation therapy, or bowel surgery.
Gastroenterologist Dr. George Nikias explains the common causes, symptoms and treatments for ulcerative colitis, one of the most common inflammatory bowel diseases.
Ulcerative colitis treatment The range of medications for UC includes anti-inflammatory drugs such as corticosteroids, immune system suppressors and biologics that target proteins made by the ...
For ulcerative colitis, mirikizumab has been recently approved, but we’re also expecting other IL-23 inhibitors to come into play in the next few months, guselkumab and risankizumab.
Medical treatments for ulcerative colitis typically include: Anti-inflammatory medications: These aim to reduce inflammation in the colon and may include corticosteroids and aminosalicylates.
So, we still have our tried-and-true therapies that are available for patients with mild ulcerative colitis in particular, those being in the form of mesalamine (Asacol, Salix Pharmaceuticals ...
The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular ...